ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
6‑Alkynyl- and 6‑Aryl-Substituted
(R)‑Pipecolic Acid Derivatives
Amina Sadiq and Norbert Sewald*
Department of Chemistry, Bielefeld University, P.O. Box 100131, 33501 Bielefeld,
Germany
Received April 18, 2013
ABSTRACT
(R)-R-Aminoadipic acid is a readily available enantiomerically pure starting material for the synthesis of (R)-pipecolic acid and its derivatives.
Sonogashira or Suzuki cross-coupling reactions of an N-formyl pipecolate-derived vinyl bromide furnish 6-alkynyl or aryl derivatives. Reduction
with sodium cyanoborohydride and subsequent N-deformylation provide 6-alkynyl substituted (R)-pipecolic acid derivatives, valuable building
blocks for amino acid and peptide chemistry.
Amino acids are versatile chiral pool building blocks in
peptidechemistry, organicsynthesis, and organocatalysis.1
D-Amino acids are not as abundant in Nature as the
L-configured counterparts. However, D-amino acids signifi-
cantly influence the conformation of e.g. cyclic peptides.2
R-Aminoadipic acid, the homologue of glutamic acid, is a
naturally occurring amino acid found in green plants and
microorganisms.3,4 It is an intermediate in lysine meta-
bolism.5 (R)-R-Aminoadipic acid 1 constitutes the acyl
substituent present in penicillin N and cephalosporin
C. It is cleaved in the semisynthesis of β-lactam antibiotics
to give 7-aminocephalosporanic acid (7-ACA), which is
subsequently acylated in order to introduce different side
chains. Onlyrecently, anenzymaticprocesswasdeveloped,
which provides (R)-R-aminoadipic acid in large quantities
by cleavage from the fermentation product cephalosporin
C using cephalosporin acylase.6
(R)-R-Aminoadipic acid has been proven to be a con-
venient chiral pool starting material for the synthesis of
(R)-pipecolic acid and its derivatives.7 Pipecolic acid, also
known ashomoprolineorpiperidine-2-carboxylic acid, isa
component of several secondary metabolites in plants and
fungi. (S)-Pipecolic acid occurs in many natural products
with interesting biological activities, like the anticancer
agent VX710,8 the antibiotic sandramycin,9 the immuno-
suppressants FK 50610 and rapamycin,11 the histone de-
acetylase (HDAC) inhibitors WF-3161 and Cyl-2,12 and
the ATPase inhibiting efrapeptins and neo-efrapeptins.13
(R)-Pipecolic acid is a constituent of the HDAC inhi-
bitors trapoxin A and apicidin.14 Substituted derivatives
of pipecolic acid are valuable building blocks for
(7) Sadiq, A.; Sewald, N. ARKIVOC 2012, (v), 28–36.
(8) Germann, U. A.; Shlyakhter, D.; Mason, V. S.; Zelle, R. E.;
Duffy, J. P.; Galullo, V.; Armistead, D. M.; Saunders, J. O.; Boger, J.;
Harding, M. W. Anticancer Drugs 1997, 8, 125–140.
(1) (a) Moloney, M. G. Synthons derived from aspartic and glutamic
acid. In Amino Acid Derivatives: A practical approach; Barrett, G. C., Ed.;
Oxford University Press: Oxford, 1999. (b) Xie, H.; Hayes, T.; Gathergood,
N. Catalysis of Reactions by Amino Acids. In Amino Acids, Peptides and
Proteins in Organic Chemistry; Hughes, A. B., Ed.; Wiley-VCH: Weinheim,
2009.
(9) Boger, D. L.; Chen, J.-H.; Saionz, K. W. J. Am. Chem. Soc. 1996,
118, 1629–1644.
(10) Nakatsuka, M.; Ragan, J. A.; Sammakia, T.; Smith, D. B.;
Uehling, D. E.; Schreiber, S. L. J. Am. Chem. Soc. 1990, 112, 5583–5601.
(11) Gatto, G. J., Jr.; Boyne, M.T., II; Kelleher, N. L.; Walsh, C. T.
J. Am. Chem. Soc. 2006, 128, 3838–3847.
(2) Royo Gracia, S.; Gaus, K.; Sewald, N. Future Med. Chem. 2009,
1, 1289–1310.
(12) Taunton, J.; Collins, J. L.; Schreiber, S. L. J. Am. Chem. Soc.
1996, 118, 10412–10422.
(3) Barton, H. R. D.; Herve, Y.; Potier, P.; Thierry, J. Tetrahedron
1987, 4297–4308.
(4) Takano, S.; Kamikubo, T.; Moriya, M.; Ogasawara, K. Synthesis
(13) Weigelt, S.; Huber, T.; Hofmann, F.; Jost, M.; Ritzefeld, M.;
Luy, B.; Freudenberger, C.; Majer, Z.; Vass, E.; Greie, J. C.; Panella, L.;
ꢀ
Kaptein, B.; Broxterman, Q. B.; Kessler, H.; Altendorf, K.; Hollosi, M.;
1994, 601–604.
Sewald, N. Chem.;Eur. J. 2012, 18, 478–487.
(14) Miller, T. A.; Witter, D. J.; Belvedere, S. J. Med. Chem. 2003, 46,
5097–5116.
(5) Zhu, X.; Tang, G.; Galili, G. Biochem. J. 2000, 351, 215–220.
(6) Sonawane, V. C. Crit. Rev. Biotechnol. 2006, 26, 95–120.
r
10.1021/ol4010728
XXXX American Chemical Society